The antiestrogen ICI 182780 disrupts estrogen receptor nucleocytoplasmic shuttling

QUICK SEARCH:

[advanced]

	Author:		Keyword(s):

Home Help Feedback Subscriptions Archive Search Table of Contents

This Article

	Summary
	Full Text (PDF)
	Alert me when this article is cited
	Alert me if a correction is posted

Services

	Email this article to a friend
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new issues of the journal
	Download to citation manager


Citing Articles

	Citing Articles via HighWire
	Citing Articles via Google Scholar

Google Scholar

	Articles by Dauvois, S.
	Articles by Parker, M. G.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Dauvois, S.
	Articles by Parker, M. G.


Social Bookmarking

	What's this?

Arbuckle, N. D., Dauvois S. and Parker, M. G (1992). Effects of antioestrogens on the DNA binding activity of oestrogen receptors in vitro. Nucl. Acids Res 20, 3839-3844.[Abstract/Free Full Text]

Barsony, J., Pike, J. W., De Luca, H. F. and Marx, S. J (1990). Immunocytology with microwave-fixed fibroblasts shows 1a,25-dihydroxyvitamin D3-dependent rapid and estrogen-dependent slow reorganization of vitamin D receptors. J. Cell Biol 11, 2385-2395.

Beato, M (1989). Gene regulation by steroid hormones. Cell 56, 335-344.[Medline]

Berry, M., Metzger, D. and Chambon, P (1990). Role of the two activating domains of the oestrogen receptor in the cell-type and promoter-context dependent agonistic activity of the anti-oestrogen 4-hydroxytamoxifen. EMBO J 9, 2811-2818.[Medline]

Borer, R. A., Lehner, C. F., Eppenberger, H. M. and Nigg, E. A (1989). Major nucleolar proteins shuttle between nucleus and cytoplasm. Cell 56, 379-390.[Medline]

Bowler, J., Lilley, T. J., Pittam J. D. and Wakeling, A. E (1989). Novel steroidal pure antiestrogens. Steroids 54, 71-99.[Medline]

Chandran, U. R. and De Franco, D. B (1992). Internuclear migration of chicken progesterone receptor, but not simian virus-40 large tumor antigen, in transient heterokaryons. Mol. Endocrinol 6, 837-844.[Abstract/Free Full Text]

Dauvois, S., Danielian, P. S., White, R. and Parker, M. G (1992). Antiestrogen ICI 164,384 reduces cellular estrogen receptor content by increasing its turnover. Proc. Nat. Acad. Sci. USA 89, 4037-4041.[Abstract/Free Full Text]

De Franco, D. B., Qi, M., Borror, K. C., Garabedian, M. J. and Brautigan, D. L (1991). Protein phosphatase types 1 and/or 2A regulate nucleocytoplasmic shuttling of glucocorticoid receptors. Mol. Endocrinol 5, 1215-1228.[Abstract/Free Full Text]

Dingwall, C. and Laskey, R. A (1991). Nuclear targeting sequences- a consensus?. Trends Biochem. Sci 16, 478-481.[Medline]

Evans, R. M (1988). The steroid and thyroid hormone receptor superfamily. Science 240, 889-895.[Abstract/Free Full Text]

Fawell, S. E., Lees, J. A., White, R. and Parker, M. G (1990). Characterization and colocalization of steroid binding and dimerization activities in the mouse estrogen receptor. Cell 60, 953-962.[Medline]

Fawell, S. E., White, R., Hoare, S., Sydenham, M., Page, M. and Parker, M. G (1990). Inhibition of estrogen receptor-DNA binding by the \324pure' antiestrogen ICI 164,384 appears to be mediated by impaired receptor dimerization. Proc. Nat. Acad. Sci. USA 87, 6883-6887.[Abstract/Free Full Text]

Gibson, M. K., Nemmers, L. A., Beckman, W. C. Jr, Davis, V. L., Curtis, S. W. and Korach, K. S (1991). The mechanism of ICI 164,384 antiestrogenicity involves rapid loss of estrogen receptor in uterine tissue. Endocrinology 129, 2000-2010.[Abstract/Free Full Text]

Greene, G. L., Sobel, N. B., King, W. J. and Jensen, E. V (1984). Immunochemical studies of estrogen receptors. J. Steroid Biochem 20, 51-6.[Medline]

Guiochon-Mantel, A., Loosfelt, H. Lescop, P., Sar, S., Atger, M., Perrot-Applanat, M. and Milgrom, E (1989). Mechanisms of nuclear localization of the progesterone receptor, evidence for interaction between monomers. Cell 57, 1147-1154.[Medline]

Guiochon-Mantel, A., Lescop, P., Christin-Maitre, S., Loosfelt, H., Perrot-Applanat, M. and Milgrom, E (1991). Nucleocytoplasmic shuttling of the progesterone receptor. EMBO J 10, 3851-3859.[Medline]

Ham, J. and Parker, M. G (1989). Regulation of gene expression by nuclear hormone receptors. Curr. Opin. Cell Biol 1, 503-511.[Medline]

Hsu, S.-C., Qi, M. and De Franco, D. B (1992). Cell cycle regulation of glucocorticoid receptor function. EMBO J 11, 3457-3468.[Medline]

Ignar-Trowbridge, D. M., Nelson, K. G., Bidwell, M. C., Curtis, S. W., Washburn, T. F., McLachlan, J. A. and Korach, K. S (1992). Coupling of dual signaling pathways: epidermal growth factor action involves the estrogen receptor. Proc. Nat. Acad. Sci. USA 89, 4658-4662.[Abstract/Free Full Text]

Jenster, G., Van der Korput, A. G. M., Trapman, J. and Brinkmann, A. O (1992). Functional domains of the human androgen receptor. J. Steroid Biochem. Molec. Biol 41, 671-675.[Medline]

Jordan, V. C (1984). Biochemical pharmacology of antiestrogen action. Pharmacol. Rev 36, 245-76.[Medline]

Jordan, V. C. and Murphy, C. S (1990). Endocrine pharmacology of antiestrogens as antitumor agents. Endocrine Rev 11, 578-610.[Abstract/Free Full Text]

Kalderon, D., Richardson, W. D., Markham, A. T. and Smith, A. E (1984). Sequence requirements for nuclear location of simian virus 40 large-T antigen. Nature 311, 33-38.[Medline]

Kalderon, D., Roberts, B. L., Richardson, W. D. and Smith, A. E (1984). A short amino acid sequence able to specify nuclear location. Cell 39, 499-509.[Medline]

Kemppainen, J. A., Lane, M. V., Sar, M. and Wilson, E. M (1992). Androgen receptor phosphorylation, turnover, nuclear transport, and transcriptional activation. J. Biol. Chem 267, 968-974.[Abstract/Free Full Text]

King, W. J. and Greene, G. L (1984). Monoclonal antibodies localize oestrogen receptor in the nuclei of target cells. Nature 307, 745-7.[Medline]

Kumar, V., Green, S., Staub, A. and Chambon, P (1986). Localisation of the oestradiol-binding and putative DNA-binding domains of the human oestrogen receptor. EMBO J 5, 2231-2236.[Medline]

Lanford, R. E. and Butel, J. S (1984). Construction and characterization of an SV40 mutant defective in nuclear transport of T antigen. Cell 37, 801-813.[Medline]

Lee, Y. and Mahdavi, V (1993). The D domain of the thyroid hormone receptor alpha1 specifies positive and negative transcriptional regulation functions. J. Biol. Chem 268, 2021-2028.[Abstract/Free Full Text]

Lees, J. A., Fawell, S. E. and Parker, M. G (1989). Identification of two transactivation domains in the mouse oestrogen receptor. Nucl. Acids Res 17, 5477-5488.[Abstract/Free Full Text]

Mandell, R. B. and Feldherr, C. M (1990). Identification of two HSP70-related Xenopus oocyte proteins that are capable of recycling across the nuclear envelope. J. Cell Biol 111, 1775-1783.[Abstract/Free Full Text]

Morgenstern, J. P. and Land, H (1990). A series of mammalian expression vectors and characterisation of their expression of a reporter gene in stably and transiently transfected cells. Nucl. Acids Res 18, 1068-.[Free Full Text]

Perrot-Applanat, M., Logeat, F., Groyer-Picard, M. T. and Milgrom, E (1985). Immunocytochemical study of mammalian progesterone receptor using monoclonal antibodies. Endocrinol 116, 1473-84.[Abstract/Free Full Text]

Picard, D. and Yamamoto, K. R (1987). Two signals mediate hormone-dependent nuclear localization of the glucocorticoid receptor. EMBO J 6, 3333-40.[Medline]

Picard, D., Kumar, V., Chambon, P. and Yamamoto, K. R (1990). Signal transduction by steroid hormones: nuclear localization is differentially regulated in estrogen and glucocorticoid receptors. Cell Regul 1, 291-299.[Medline]

Power, R. F., Mani, S. K., Codina, J., Conneely, O. M. and O'Malley, B.1388W (1991). Dopaminergic and ligand-independent activation of steroid hormone receptors. Science 254, 1636-1639.[Abstract/Free Full Text]

Reese, J. C. and Katzenellenbogen, B. S (1992). Examination of the DNA-binding ability of estrogen receptor in whole cells: implications for hormone-dependent transactivation and the actions of antiestrogens. Mol. Cell. Biol 12, 4531-4538.[Abstract/Free Full Text]

Shi, Y. and Thomas, J. O (1992). The transport of proteins into the nucleus requires the 70-kilodalton heat shock protein or its cytosolic cognate. Mol. Cell. Biol 12, 2186-2192.[Abstract/Free Full Text]

Tora, L., Mullick, A., Metzger, D., Ponglikitmongkol, M., Park, I. and Chambon, P (1989). The cloned human oestrogen receptor contains amutation which alters its hormone binding properties. EMBO J 8, 1981-1986.[Medline]

Wakeling, A. E., Dukes, M. and Bowler, J (1991). A potent specific pure antiestrogen with clinical potential. Cancer Res 51, 3867-3873.[Abstract/Free Full Text]

Welshons, W. V., Krummel, B. M. and Gorski, J (1985). Nuclear localization of unoccupied receptors for glucocorticoids, estrogens, and progesterone in GH3 cells. Endocrinology 117, 2140-7.[Abstract/Free Full Text]

White, R., Lees, J. A., Needham, M., Ham, J. and Parker, M (1987). Structural organization and expression of the mouse estrogen receptor. Mol. Endocrinol 1, 735-744.[Abstract/Free Full Text]

Ylikomi, T., Bocquel, M. T., Berry, M., Gronemeyer, H. and Chambon, P (1992). Cooperation of proto-signals for nuclear accumulation of estrogen and progesterone receptors. EMBO J 11, 1-14.[Medline]

CiteULike

Complore

Connotea

Del.icio.us Add to Digg

Digg

Technorati

Twitter What's this?

This article has been cited by other articles:

C. A. Oliveira, A. B. Victor-Costa, and R. A. Hess
Cellular and Regional Distributions of Ubiquitin-Proteasome and Endocytotic Pathway Components in the Epithelium of Rat Efferent Ductules and Initial Segment of the Epididymis
J Androl, September 1, 2009; 30(5): 590 - 601.
[Abstract] [Full Text] [PDF]

I. Barone, Y. Cui, M. H. Herynk, A. Corona-Rodriguez, C. Giordano, J. Selever, A. Beyer, S. Ando, and S. A.W. Fuqua
Expression of the K303R Estrogen Receptor-{alpha} Breast Cancer Mutation Induces Resistance to an Aromatase Inhibitor via Addiction to the PI3K/Akt Kinase Pathway
Cancer Res., June 1, 2009; 69(11): 4724 - 4732.
[Abstract] [Full Text] [PDF]

G. Giamas, L. Castellano, Q. Feng, U. Knippschild, J. Jacob, R. S. Thomas, R. C. Coombes, C. L. Smith, L. R. Jiao, and J. Stebbing
CK1{delta} modulates the transcriptional activity of ER{alpha} via AIB1 in an estrogen-dependent manner and regulates ER{alpha}-AIB1 interactions
Nucleic Acids Res., May 1, 2009; 37(9): 3110 - 3123.
[Abstract] [Full Text] [PDF]

P. Fan, W. Yue, J.-P. Wang, S. Aiyar, Y. Li, T.-H. Kim, and R. J. Santen
Mechanisms of Resistance to Structurally Diverse Antiestrogens Differ under Premenopausal and Postmenopausal Conditions: Evidence from in Vitro Breast Cancer Cell Models
Endocrinology, May 1, 2009; 150(5): 2036 - 2045.
[Abstract] [Full Text] [PDF]

Y. Zhang, H. Zhao, S. Asztalos, M. Chisamore, Y. Sitabkhan, and D. A. Tonetti
Estradiol-Induced Regression in T47D:A18/PKC{alpha} Tumors Requires the Estrogen Receptor and Interaction with the Extracellular Matrix
Mol. Cancer Res., April 1, 2009; 7(4): 498 - 510.
[Abstract] [Full Text] [PDF]

C. E. Ford, E. J. Ekstrom, and T. Andersson
From the Cover: Wnt-5a signaling restores tamoxifen sensitivity in estrogen receptor-negative breast cancer cells
PNAS, March 10, 2009; 106(10): 3919 - 3924.
[Abstract] [Full Text] [PDF]

S. M. Fernandez, M. C. Lewis, A. S. Pechenino, L. L. Harburger, P. T. Orr, J. E. Gresack, G. E. Schafe, and K. M. Frick
Estradiol-Induced Enhancement of Object Memory Consolidation Involves Hippocampal Extracellular Signal-Regulated Kinase Activation and Membrane-Bound Estrogen Receptors
J. Neurosci., August 27, 2008; 28(35): 8660 - 8667.
[Abstract] [Full Text] [PDF]

M. Lombardi, G. Castoria, A. Migliaccio, M. V. Barone, R. Di Stasio, A. Ciociola, D. Bottero, H. Yamaguchi, E. Appella, and F. Auricchio
Hormone-dependent nuclear export of estradiol receptor and DNA synthesis in breast cancer cells
J. Cell Biol., July 28, 2008; 182(2): 327 - 340.
[Abstract] [Full Text] [PDF]

J. A. Greenberg, S. Somme, H. E. Russnes, A. D. Durbin, and D. Malkin
The Estrogen Receptor Pathway in Rhabdomyosarcoma: A Role for Estrogen Receptor-{beta} in Proliferation and Response to the Antiestrogen 4'OH-Tamoxifen
Cancer Res., May 1, 2008; 68(9): 3476 - 3485.
[Abstract] [Full Text] [PDF]

S. Chia, W. Gradishar, L. Mauriac, J. Bines, F. Amant, M. Federico, L. Fein, G. Romieu, A. Buzdar, J. F.R. Robertson, et al.
Double-Blind, Randomized Placebo Controlled Trial of Fulvestrant Compared With Exemestane After Prior Nonsteroidal Aromatase Inhibitor Therapy in Postmenopausal Women With Hormone Receptor-Positive, Advanced Breast Cancer: Results From EFECT
J. Clin. Oncol., April 1, 2008; 26(10): 1664 - 1670.
[Abstract] [Full Text] [PDF]

P. A. Pioli, A. L. Jensen, L. K. Weaver, E. Amiel, Z. Shen, L. Shen, C. R. Wira, and P. M. Guyre
Estradiol Attenuates Lipopolysaccharide-Induced CXC Chemokine Ligand 8 Production by Human Peripheral Blood Monocytes
J. Immunol., November 1, 2007; 179(9): 6284 - 6290.
[Abstract] [Full Text] [PDF]

C. T. Kesler, D. Gioeli, M. R. Conaway, M. J. Weber, and B. M. Paschal
Subcellular Localization Modulates Activation Function 1 Domain Phosphorylation in the Androgen Receptor
Mol. Endocrinol., September 1, 2007; 21(9): 2071 - 2084.
[Abstract] [Full Text] [PDF]

D. Nonclercq, F. Journe, I. Laios, C. Chaboteaux, R.-A. Toillon, G. Leclercq, and G. Laurent
Effect of nuclear export inhibition on estrogen receptor regulation in breast cancer cells
J. Mol. Endocrinol., August 1, 2007; 39(2): 105 - 118.
[Abstract] [Full Text] [PDF]

J. D. Wren, Y. Wu, and S.-W. Guo
A system-wide analysis of differentially expressed genes in ectopic and eutopic endometrium
Hum. Reprod., August 1, 2007; 22(8): 2093 - 2102.
[Abstract] [Full Text] [PDF]

D. Gallo, E. Mantuano, M. Fabrizi, C. Ferlini, S. Mozzetti, I. De Stefano, and G. Scambia
Effects of a phytoestrogen-containing soy extract on the growth-inhibitory activity of ICI 182 780 in an experimental model of estrogen-dependent breast cancer
Endocr. Relat. Cancer, June 1, 2007; 14(2): 317 - 324.
[Abstract] [Full Text] [PDF]

M. Lupien, M. Jeyakumar, E. Hebert, K. Hilmi, D. Cotnoir-White, C. Loch, A. Auger, G. Dayan, G.-A. Pinard, J.-M. Wurtz, et al.
Raloxifene and ICI182,780 Increase Estrogen Receptor-{alpha} Association with a Nuclear Compartment via Overlapping Sets of Hydrophobic Amino Acids in Activation Function 2 Helix 12
Mol. Endocrinol., April 1, 2007; 21(4): 797 - 816.
[Abstract] [Full Text] [PDF]

M. Nichols
The Fight Against Tamoxifen Resistance in Breast Cancer Therapy: A New Target in the Battle?
Mol. Interv., February 1, 2007; 7(1): 13 - 16.
[Abstract] [Full Text] [PDF]

P. Fan, J. Wang, R. J. Santen, and W. Yue
Long-term Treatment with Tamoxifen Facilitates Translocation of Estrogen Receptor {alpha} out of the Nucleus and Enhances its Interaction with EGFR in MCF-7 Breast Cancer Cells
Cancer Res., February 1, 2007; 67(3): 1352 - 1360.
[Abstract] [Full Text] [PDF]

L. Zhao, K. O'Neill, and R. D. Brinton
Estrogenic Agonist Activity of ICI 182,780 (Faslodex) in Hippocampal Neurons: Implications for Basic Science Understanding of Estrogen Signaling and Development of Estrogen Modulators with a Dual Therapeutic Profile
J. Pharmacol. Exp. Ther., December 1, 2006; 319(3): 1124 - 1132.
[Abstract] [Full Text] [PDF]

B. M. Jaber, T. Gao, L. Huang, S. Karmakar, and C. L. Smith
The Pure Estrogen Receptor Antagonist ICI 182,780 Promotes a Novel Interaction of Estrogen Receptor-{alpha} with the 3',5'-Cyclic Adenosine Monophosphate Response Element-Binding Protein-Binding Protein/p300 Coactivators
Mol. Endocrinol., November 1, 2006; 20(11): 2695 - 2710.
[Abstract] [Full Text] [PDF]

A. Howell
Pure oestrogen antagonists for the treatment of advanced breast cancer.
Endocr. Relat. Cancer, September 1, 2006; 13(3): 689 - 706.
[Abstract] [Full Text] [PDF]

J. M. Garcia-Pedrero, E. Kiskinis, M. G. Parker, and B. Belandia
The SWI/SNF Chromatin Remodeling Subunit BAF57 Is a Critical Regulator of Estrogen Receptor Function in Breast Cancer Cells
J. Biol. Chem., August 11, 2006; 281(32): 22656 - 22664.
[Abstract] [Full Text] [PDF]

R. S. Bhattacharyya, A. V. Krishnan, S. Swami, and D. Feldman
Fulvestrant (ICI 182,780) down-regulates androgen receptor expression and diminishes androgenic responses in LNCaP human prostate cancer cells.
Mol. Cancer Ther., June 1, 2006; 5(6): 1539 - 1549.
[Abstract] [Full Text] [PDF]

X. Long and K. P. Nephew
Fulvestrant (ICI 182,780)-dependent Interacting Proteins Mediate Immobilization and Degradation of Estrogen Receptor-{alpha}
J. Biol. Chem., April 7, 2006; 281(14): 9607 - 9615.
[Abstract] [Full Text] [PDF]

L. Lipfert, J. E. Fisher, N. Wei, A. Scafonas, Q. Su, J. Yudkovitz, F. Chen, S. Warrier, E. T. Birzin, S. Kim, et al.
Antagonist-Induced, Activation Function-2-Independent Estrogen Receptor {alpha} Phosphorylation
Mol. Endocrinol., March 1, 2006; 20(3): 516 - 533.
[Abstract] [Full Text] [PDF]

H.-P. Yu, M. A. Choudhry, T. Shimizu, Y.-C. Hsieh, M. G. Schwacha, S. Yang, and I. H. Chaudry
Mechanism of the salutary effects of flutamide on intestinal myeloperoxidase activity following trauma-hemorrhage: up-regulation of estrogen receptor-{beta}-dependent HO-1
J. Leukoc. Biol., February 1, 2006; 79(2): 277 - 284.
[Abstract] [Full Text] [PDF]

M. Fan, A. Park, and K. P. Nephew
CHIP (Carboxyl Terminus of Hsc70-Interacting Protein) Promotes Basal and Geldanamycin-Induced Degradation of Estrogen Receptor-{alpha}
Mol. Endocrinol., December 1, 2005; 19(12): 2901 - 2914.
[Abstract] [Full Text] [PDF]

H.-J. Kim, Y. I. Park, and M.-S. Dong
Effects of 2,4-D and DCP on the DHT-Induced Androgenic Action in Human Prostate Cancer Cells
Toxicol. Sci., November 1, 2005; 88(1): 52 - 59.
[Abstract] [Full Text] [PDF]

F. F. Zheng, R.-C. Wu, C. L. Smith, and B. W. O'Malley
Rapid Estrogen-Induced Phosphorylation of the SRC-3 Coactivator Occurs in an Extranuclear Complex Containing Estrogen Receptor
Mol. Cell. Biol., September 15, 2005; 25(18): 8273 - 8284.
[Abstract] [Full Text] [PDF]

K-M Rau, H-Y Kang, T-L Cha, S A Miller, and M-C Hung
The mechanisms and managements of hormone-therapy resistance in breast and prostate cancers
Endocr. Relat. Cancer, September 1, 2005; 12(3): 511 - 532.
[Abstract] [Full Text] [PDF]

R. F. Walther, E. Atlas, A. Carrigan, Y. Rouleau, A. Edgecombe, L. Visentin, C. Lamprecht, G. C. Addicks, R. J. G. Hache, and Y. A. Lefebvre
A Serine/Threonine-rich Motif Is One of Three Nuclear Localization Signals That Determine Unidirectional Transport of the Mineralocorticoid Receptor to the Nucleus
J. Biol. Chem., April 29, 2005; 280(17): 17549 - 17561.
[Abstract] [Full Text] [PDF]

X.-F. Lin, B.-X. Zhao, H.-Z. Chen, X.-F. Ye, C.-Y. Yang, H.-Y. Zhou, M.-Q. Zhang, S.-C. Lin, and Q. Wu
RXR{alpha} acts as a carrier for TR3 nuclear export in a 9-cis retinoic acid-dependent manner in gastric cancer cells
J. Cell Sci., November 1, 2004; 117(23): 5609 - 5621.
[Abstract] [Full Text] [PDF]

H. C. Whitaker, S. Hanrahan, N. Totty, S. C. Gamble, J. Waxman, A. C. B. Cato, H. C. Hurst, and C. L. Bevan
Androgen Receptor Is Targeted to Distinct Subcellular Compartments in Response to Different Therapeutic Antiandrogens
Clin. Cancer Res., November 1, 2004; 10(21): 7392 - 7401.
[Abstract] [Full Text] [PDF]

P. Cheng, B. Kanterewicz, P. A. Hershberger, K. S. McCarty Jr., B. W. Day, and M. Nichols
Inhibition of Estrogen Receptor {alpha}-Mediated Transcription by Antiestrogenic 1,1-Dichloro-2,2,3-triarylcyclopropanes
Mol. Pharmacol., October 1, 2004; 66(4): 970 - 977.
[Abstract] [Full Text] [PDF]

C. L. Smith and B. W. O'Malley
Coregulator Function: A Key to Understanding Tissue Specificity of Selective Receptor Modulators
Endocr. Rev., February 1, 2004; 25(1): 45 - 71.
[Abstract] [Full Text] [PDF]

A. M. FOWLER, N. SOLODIN, M. T. PREISLER-MASHEK, P. ZHANG, A. V. LEE, and E. T. ALARID
Increases in estrogen receptor-{alpha} concentration in breast cancer cells promote serine 118/104/106-independent AF-1 transactivation and growth in the absence of estrogen
FASEB J, January 1, 2004; 18(1): 81 - 93.
[Abstract] [Full Text] [PDF]

C. Osipo, C. Gajdos, H. Liu, B. Chen, and V. C. Jordan
Paradoxical Action of Fulvestrant in Estradiol-Induced Regression of Tamoxifen-Stimulated Breast Cancer
J Natl Cancer Inst, November 5, 2003; 95(21): 1597 - 1608.
[Abstract] [Full Text] [PDF]

R. F. Walther, C. Lamprecht, A. Ridsdale, I. Groulx, S. Lee, Y. A. Lefebvre, and R. J. G. Hache
Nuclear Export of the Glucocorticoid Receptor Is Accelerated by Cell Fusion-dependent Release of Calreticulin
J. Biol. Chem., September 26, 2003; 278(39): 37858 - 37864.
[Abstract] [Full Text] [PDF]

M. Piccart, L. M. Parker, and K. I. Pritchard
Oestrogen receptor downregulation: an opportunity for extending the window of endocrine therapy in advanced breast cancer
Ann. Onc., July 1, 2003; 14(7): 1017 - 1025.
[Abstract] [Full Text] [PDF]

K. M. M. Kelley, B. G. Rowan, and M. Ratnam
Modulation of the Folate Receptor {alpha} Gene by the Estrogen Receptor: Mechanism and Implications in Tumor Targeting
Cancer Res., June 1, 2003; 63(11): 2820 - 2828.
[Abstract] [Full Text] [PDF]

P. Dan, J. C. Y. Cheung, D. R. L. Scriven, and E. D. W. Moore
Epitope-dependent localization of estrogen receptoralpha , but not -beta , in en face arterial endothelium
Am J Physiol Heart Circ Physiol, April 1, 2003; 284(4): H1295 - H1306.
[Abstract] [Full Text] [PDF]

P. Maruvada, C. T. Baumann, G. L. Hager, and P. M. Yen
Dynamic Shuttling and Intranuclear Mobility of Nuclear Hormone Receptors
J. Biol. Chem., March 28, 2003; 278(14): 12425 - 12432.
[Abstract] [Full Text] [PDF]

B. T. Akingbemi, R. Ge, C. S. Rosenfeld, L. G. Newton, D. O. Hardy, J. F. Catterall, D. B. Lubahn, K. S. Korach, and M. P. Hardy
Estrogen Receptor-{alpha} Gene Deficiency Enhances Androgen Biosynthesis in the Mouse Leydig Cell
Endocrinology, January 1, 2003; 144(1): 84 - 93.
[Abstract] [Full Text] [PDF]

M. Obrero, D. V. Yu, and D. J. Shapiro
Estrogen Receptor-dependent and Estrogen Receptor-independent Pathways for Tamoxifen and 4-Hydroxytamoxifen-induced Programmed Cell Death
J. Biol. Chem., November 15, 2002; 277(47): 45695 - 45703.
[Abstract] [Full Text] [PDF]

L. Bjornstrom and M. Sjoberg
Signal Transducers and Activators of Transcription as Downstream Targets of Nongenomic Estrogen Receptor Actions
Mol. Endocrinol., October 1, 2002; 16(10): 2202 - 2214.
[Abstract] [Full Text] [PDF]

H. Lee and W. Bai
Regulation of Estrogen Receptor Nuclear Export by Ligand-Induced and p38-Mediated Receptor Phosphorylation
Mol. Cell. Biol., August 15, 2002; 22(16): 5835 - 5845.
[Abstract] [Full Text] [PDF]

K. Prufer and J. Barsony
Retinoid X Receptor Dominates the Nuclear Import and Export of the Unliganded Vitamin D Receptor
Mol. Endocrinol., August 1, 2002; 16(8): 1738 - 1751.
[Abstract] [Full Text] [PDF]

P. Yi, S. Bhagat, R. Hilf, R. A. Bambara, and M. Muyan
Differences in the Abilities of Estrogen Receptors to Integrate Activation Functions Are Critical for Subtype-Specific Transcriptional Responses
Mol. Endocrinol., August 1, 2002; 16(8): 1810 - 1827.
[Abstract] [Full Text] [PDF]

A. D. Papaconstantinou, B. R. Fisher, T. H. Umbreit, P. L. Goering, N. T. Lappas, and K. M. Brown
Effects of {beta}-Estradiol and Bisphenol A on Heat Shock Protein Levels and Localization in the Mouse Uterus Are Antagonized by the Antiestrogen ICI 182,780
Toxicol. Sci., October 1, 2001; 63(2): 173 - 180.
[Abstract] [Full Text] [PDF]

J. F. Robertson, R. I. Nicholson, N. J. Bundred, E. Anderson, Z. Rayter, M. Dowsett, J. N. Fox, J. M. W. Gee, A. Webster, A. E. Wakeling, et al.
Comparison of the Short-Term Biological Effects of 7{alpha}-[9-(4,4,5,5,5-pentafluoropentylsulfinyl)-nonyl]estra-1,3,5, (10)-triene-3,17{beta}-diol (Faslodex) versus Tamoxifen in Postmenopausal Women with Primary Breast Cancer
Cancer Res., September 1, 2001; 61(18): 6739 - 6746.
[Abstract] [Full Text] [PDF]

C. A. Oliveira, K. Carnes, L. R. Franca, and R. A. Hess
Infertility and Testicular Atrophy in the Antiestrogen-Treated Adult Male Rat
Biol Reprod, September 1, 2001; 65(3): 913 - 920.
[Abstract] [Full Text] [PDF]

C. Pasqualini, D. Guivarc'h, J.-V. Barnier, B. Guibert, J.-D. Vincent, and P. Vernier
Differential Subcellular Distribution and Transcriptional Activity of {{Sigma}}E3, {{Sigma}}E4, and {{Sigma}}E3-4 Isoforms of the Rat Estrogen Receptor-{{alpha}}
Mol. Endocrinol., June 1, 2001; 15(6): 894 - 908.
[Abstract] [Full Text] [PDF]

D. Marcantonio, L. E. Chalifour, M. A. Alaoui-Jamali, L. Alpert, and H. T. Huynh
Cloning and Characterization of a Novel Gene That Is Regulated by Estrogen and Is Associated with Mammary Gland Carcinogenesis
Endocrinology, June 1, 2001; 142(6): 2409 - 2418.
[Abstract] [Full Text] [PDF]

D. J. Bentrem, R. C. Dardes, H. Liu, J. MacGregor-Schafer, J. W. Zapf, and V. C. Jordan
Molecular Mechanism of Action at Estrogen Receptor {{alpha}} of a New Clinically Relevant Antiestrogen (GW7604) Related to Tamoxifen
Endocrinology, February 1, 2001; 142(2): 838 - 846.
[Abstract] [Full Text] [PDF]

Y. Wan, K. K. Coxe, V. G. Thackray, P. R. Housley, and S. K. Nordeen
Separable Features of the Ligand-Binding Domain Determine the Differential Subcellular Localization and Ligand-Binding Specificity of Glucocorticoid Receptor and Progesterone Receptor
Mol. Endocrinol., January 1, 2001; 15(1): 17 - 31.
[Abstract] [Full Text]

C. K. Osborne and S. A. W. Fuqua
Selective Estrogen Receptor Modulators: Structure, Function, and Clinical Use
J. Clin. Oncol., September 17, 2000; 18(17): 3172 - 3186.
[Abstract] [Full Text] [PDF]

J. M. Schafer, H. Liu, D. J. Bentrem, J. W. Zapf, and V. C. Jordan
Allosteric Silencing of Activating Function 1 in the 4-Hydroxytamoxifen Estrogen Receptor Complex Is Induced by Substituting Glycine for Aspartate at Amino Acid 351
Cancer Res., September 1, 2000; 60(18): 5097 - 5105.
[Abstract] [Full Text]

D. A. Schreihofer, M. H. Stoler, and M. A. Shupnik
Differential Expression and Regulation of Estrogen Receptors (ERs) in Rat Pituitary and Cell Lines: Estrogen Decreases ER{alpha} Protein and Estrogen Responsiveness
Endocrinology, June 1, 2000; 141(6): 2174 - 2184.
[Abstract] [Full Text] [PDF]

G. de Haan, S. Chusacultanachai, C. Mao, B. S. Katzenellenbogen, and D. J. Shapiro
Estrogen Receptor-KRAB Chimeras Are Potent Ligand-dependent Repressors of Estrogen-regulated Gene Expression
J. Biol. Chem., April 28, 2000; 275(18): 13493 - 13501.
[Abstract] [Full Text] [PDF]

H Poukka, U Karvonen, N Yoshikawa, H Tanaka, J. Palvimo, and O. Janne
The RING finger protein SNURF modulates nuclear trafficking of the androgen receptor
J. Cell Sci., January 9, 2000; 113(17): 2991 - 3001.
[Abstract] [PDF]

C. C. Zhang and D. J. Shapiro
Activation of the p38 Mitogen-activated Protein Kinase Pathway by Estrogen or by 4-Hydroxytamoxifen Is Coupled to Estrogen Receptor-induced Apoptosis
J. Biol. Chem., January 7, 2000; 275(1): 479 - 486.
[Abstract] [Full Text] [PDF]

J. Liu and D. B. DeFranco
Protracted Nuclear Export of Glucocorticoid Receptor Limits Its Turnover and Does Not Require the Exportin 1/CRM1-Directed Nuclear Export Pathway
Mol. Endocrinol., January 1, 2000; 14(1): 40 - 51.
[Abstract] [Full Text]

E. T. Alarid, N. Bakopoulos, and N. Solodin
Proteasome-Mediated Proteolysis of Estrogen Receptor: A Novel Component in Autologous Down-Regulation
Mol. Endocrinol., September 1, 1999; 13(9): 1522 - 1534.
[Abstract] [Full Text]

J. I. MacGregor Schafer, H. Liu, D. A. Tonetti, and V. C. Jordan
The Interaction of Raloxifene and the Active Metabolite of the Antiestrogen EM-800 (SC 5705) with the Human Estrogen Receptor
Cancer Res., September 1, 1999; 59(17): 4308 - 4313.
[Abstract] [Full Text] [PDF]

M. D. Galigniana, P. R. Housley, D. B. DeFranco, and W. B. Pratt
Inhibition of Glucocorticoid Receptor Nucleocytoplasmic Shuttling by Okadaic Acid Requires Intact Cytoskeleton
J. Biol. Chem., June 4, 1999; 274(23): 16222 - 16227.
[Abstract] [Full Text] [PDF]

W. G.R. Angus, M. C. Larsen, and C. R. Jefcoate
Expression of CYP1A1 and CYP1B1 depends on cell-specific factors in human breast cancer cell lines: role of estrogen receptor status
Carcinogenesis, June 1, 1999; 20(6): 947 - 955.
[Abstract] [Full Text] [PDF]

C. C. Zhang, S. Krieg, and D. J. Shapiro
HMG-1 Stimulates Estrogen Response Element Binding by Estrogen Receptor from Stably Transfected HeLa Cells
Mol. Endocrinol., April 1, 1999; 13(4): 632 - 643.
[Abstract] [Full Text]

J. Liu and D. B. DeFranco
Chromatin Recycling of Glucocorticoid Receptors: Implications for Multiple Roles of Heat Shock Protein 90
Mol. Endocrinol., March 1, 1999; 13(3): 355 - 365.
[Abstract] [Full Text]

J. G.�A. Savory, B. Hsu, I. R. Laquian, W. Giffin, T. Reich, R. J.�G. Hache, and Y. A. Lefebvre
Discrimination between NL1- and NL2-Mediated Nuclear Localization of the Glucocorticoid Receptor
Mol. Cell. Biol., February 1, 1999; 19(2): 1025 - 1037.
[Abstract] [Full Text] [PDF]

H. Htun, L. T. Holth, D. Walker, J. R. Davie, and G. L. Hager
Direct Visualization of the Human Estrogen Receptor alpha �Reveals a Role for Ligand in the Nuclear Distribution of the Receptor
Mol. Biol. Cell, February 1, 1999; 10(2): 471 - 486.
[Abstract] [Full Text]

R. J.�G. Hache, R. Tse, T. Reich, J. G.�A. Savory, and Y. A. Lefebvre
Nucleocytoplasmic Trafficking of Steroid-free Glucocorticoid Receptor
J. Biol. Chem., January 15, 1999; 274(3): 1432 - 1439.
[Abstract] [Full Text] [PDF]

Z. Nawaz, G. M. Stancel, and S. M. Hyder
The Pure Antiestrogen ICI 182,780 Inhibits Progestin-induced Transcription
Cancer Res., January 1, 1999; 59(2): 372 - 376.
[Abstract] [Full Text] [PDF]

M. D. Galigniana, J. L. Scruggs, J. Herrington, M. J. Welsh, C. Carter-Su, P. R. Housley, and W. B. Pratt
Heat Shock Protein 90-Dependent (Geldanamycin-Inhibited) Movement of the Glucocorticoid Receptor through the Cytoplasm to the Nucleus Requires Intact Cytoskeleton
Mol. Endocrinol., December 1, 1998; 12(12): 1903 - 1913.
[Abstract] [Full Text]

R. K. Tyagi, L. Amazit, P. Lescop, E. Milgrom, and A. Guiochon-Mantel
Mechanisms of Progesterone Receptor Export from Nuclei: Role of Nuclear Localization Signal, Nuclear Export Signal, and Ran Guanosine Triphosphate
Mol. Endocrinol., November 1, 1998; 12(11): 1684 - 1695.
[Abstract] [Full Text]

S. Migliaccio, T. F. Washburn, S. Fillo, H. Rivera, A. Teti, K. S. Korach, and W. C. Wetsel
Modulation of Estrogen Receptor Levels in Mouse Uterus by Protein Kinase C Isoenzymes
Endocrinology, November 1, 1998; 139(11): 4598 - 4606.
[Abstract] [Full Text] [PDF]

J. Devin-Leclerc, X. Meng, F. Delahaye, P. Leclerc, E.-E. Baulieu, and M.-G. Catelli
Interaction and Dissociation by Ligands of Estrogen Receptor and Hsp90: The Antiestrogen RU 58668 Induces a Protein Synthesis-Dependent Clustering of the Receptor in the Cytoplasm
Mol. Endocrinol., June 1, 1998; 12(6): 842 - 854.
[Abstract] [Full Text]

J. I. Macgregor and V. C. Jordan
Basic Guide to the Mechanisms of Antiestrogen Action
Pharmacol. Rev., June 1, 1998; 50(2): 151 - 196.
[Abstract] [Full Text] [PDF]

K. Yao and V. C. Jordan
Questions about Tamoxifen and the Future Use of Antiestrogens
Oncologist, April 1, 1998; 3(2): 104 - 110.
[Abstract] [Full Text]

G. F. Sewack and U. Hansen
Nucleosome Positioning and Transcription-associated Chromatin Alterations on the Human Estrogen-responsive pS2 Promoter
J. Biol. Chem., December 5, 1997; 272(49): 31118 - 31129.
[Abstract] [Full Text] [PDF]

M. Antoine, K. Reimers, C. Dickson, and P. Kiefer
Fibroblast Growth Factor 3,�a Protein with Dual Subcellular Localization, Is Targeted to the Nucleus and Nucleolus by the Concerted Action of Two Nuclear Localization Signals and a Nucleolar Retention Signal
J. Biol. Chem., November 21, 1997; 272(47): 29475 - 29481.
[Abstract] [Full Text] [PDF]

P. Pace, J. Taylor, S. Suntharalingam, R. C. Coombes, and S. Ali
Human Estrogen Receptor beta �Binds DNA in a Manner Similar to and Dimerizes with Estrogen Receptor alpha
J. Biol. Chem., October 10, 1997; 272(41): 25832 - 25838.
[Abstract] [Full Text] [PDF]

N. H. Bjarnason, J. Haarbo, I. Byrjalsen, R. F. Kauffman, and C. Christiansen
Raloxifene Inhibits Aortic Accumulation of Cholesterol in Ovariectomized, Cholesterol-Fed Rabbits
Circulation, September 16, 1997; 96(6): 1964 - 1969.
[Abstract] [Full Text]

T. M. Willson, J. D. Norris, B. L. Wagner, I. Asplin, P. Baer, H. R. Brown, S. A. Jones, B. Henke, H. Sauls, S. Wolfe, et al.
Dissection of the Molecular Mechanism of Action of GW5638, a Novel Estrogen Receptor Ligand, Provides Insights into the Role of Estrogen Receptor in Bone
Endocrinology, September 1, 1997; 138(9): 3901 - 3911.
[Abstract] [Full Text] [PDF]

W. B. Pratt and D. O. Toft
Steroid Receptor Interactions with Heat Shock Protein and Immunophilin Chaperones
Endocr. Rev., June 1, 1997; 18(3): 306 - 360.
[Abstract] [Full Text]

J. Yang, J. Liu, and D. B. DeFranco
Subnuclear Trafficking of Glucocorticoid Receptors In Vitro: Chromatin Recycling and Nuclear Export
J. Cell Biol., May 5, 1997; 137(3): 523 - 538.
[Abstract] [Full Text] [PDF]

J. P. Williams, H. C. Blair, M. A. McKenna, S. E. Jordan, and J. M. McDonald
Regulation of Avian Osteoclastic H[IMAGE]-ATPase and Bone Resorption by Tamoxifen and Calmodulin Antagonists
J. Biol. Chem., May 24, 1996; 271(21): 12488 - 12495.
[Abstract] [Full Text] [PDF]

H. Wang, G. A. Peters, X. Zeng, M. Tang, W. Ip, and S. A. Khan
Yeast Two-hybrid System Demonstrates That Estrogen Receptor Dimerization Is Ligand-dependent in Vivo
J. Biol. Chem., October 6, 1995; 270(40): 23322 - 23329.
[Abstract] [Full Text] [PDF]

L. F. Su, R. Knoblauch, and M. J. Garabedian
Rho GTPases as Modulators of the Estrogen Receptor Transcriptional Response
J. Biol. Chem., January 26, 2001; 276(5): 3231 - 3237.
[Abstract] [Full Text] [PDF]

M. Gangloff, M. Ruff, S. Eiler, S. Duclaud, J. M. Wurtz, and D. Moras
Crystal Structure of a Mutant hERalpha Ligand-binding Domain Reveals Key Structural Features for the Mechanism of Partial Agonism
J. Biol. Chem., April 27, 2001; 276(18): 15059 - 15065.
[Abstract] [Full Text] [PDF]

M. D. Galigniana, C. Radanyi, J.-M. Renoir, P. R. Housley, and W. B. Pratt
Evidence That the Peptidylprolyl Isomerase Domain of the hsp90-binding Immunophilin FKBP52 Is Involved in Both Dynein Interaction and Glucocorticoid Receptor Movement to the Nucleus
J. Biol. Chem., April 27, 2001; 276(18): 14884 - 14889.
[Abstract] [Full Text] [PDF]

R. A. Campbell, P. Bhat-Nakshatri, N. M. Patel, D. Constantinidou, S. Ali, and H. Nakshatri
Phosphatidylinositol 3-Kinase/AKT-mediated Activation of Estrogen Receptor alpha . A NEW MODEL FOR ANTI-ESTROGEN RESISTANCE
J. Biol. Chem., March 23, 2001; 276(13): 9817 - 9824.
[Abstract] [Full Text] [PDF]

A. L. Wijayaratne and D. P. McDonnell
The Human Estrogen Receptor-alpha Is a Ubiquitinated Protein Whose Stability Is Affected Differentially by Agonists, Antagonists, and Selective Estrogen Receptor Modulators
J. Biol. Chem., September 14, 2001; 276(38): 35684 - 35692.
[Abstract] [Full Text] [PDF]

M. W. Dudley, C. Q. Sheeler, H. Wang, and S. Khan
Activation of the human estrogen receptor by the antiestrogens ICI 182,780 and tamoxifen in yeast genetic systems: Implications for their mechanism of action
PNAS, March 28, 2000; 97(7): 3696 - 3701.
[Abstract] [Full Text] [PDF]

This Article

Summary

Full Text (PDF)

Alert me when this article is cited

Alert me if a correction is posted

Services

Email this article to a friend

Similar articles in this journal

Similar articles in PubMed

Alert me to new issues of the journal

Download to citation manager

Citing Articles

Citing Articles via HighWire

Citing Articles via Google Scholar

Google Scholar

Articles by Dauvois, S.

Articles by Parker, M. G.

Search for Related Content

PubMed

PubMed Citation

Articles by Dauvois, S.

Articles by Parker, M. G.

Social Bookmarking

What's this?

				I. Barone, Y. Cui, M. H. Herynk, A. Corona-Rodriguez, C. Giordano, J. Selever, A. Beyer, S. Ando, and S. A.W. Fuqua Expression of the K303R Estrogen Receptor-{alpha} Breast Cancer Mutation Induces Resistance to an Aromatase Inhibitor via Addiction to the PI3K/Akt Kinase Pathway Cancer Res., June 1, 2009; 69(11): 4724 - 4732. [Abstract] [Full Text] [PDF]

				G. Giamas, L. Castellano, Q. Feng, U. Knippschild, J. Jacob, R. S. Thomas, R. C. Coombes, C. L. Smith, L. R. Jiao, and J. Stebbing CK1{delta} modulates the transcriptional activity of ER{alpha} via AIB1 in an estrogen-dependent manner and regulates ER{alpha}-AIB1 interactions Nucleic Acids Res., May 1, 2009; 37(9): 3110 - 3123. [Abstract] [Full Text] [PDF]

				P. Fan, W. Yue, J.-P. Wang, S. Aiyar, Y. Li, T.-H. Kim, and R. J. Santen Mechanisms of Resistance to Structurally Diverse Antiestrogens Differ under Premenopausal and Postmenopausal Conditions: Evidence from in Vitro Breast Cancer Cell Models Endocrinology, May 1, 2009; 150(5): 2036 - 2045. [Abstract] [Full Text] [PDF]

				Y. Zhang, H. Zhao, S. Asztalos, M. Chisamore, Y. Sitabkhan, and D. A. Tonetti Estradiol-Induced Regression in T47D:A18/PKC{alpha} Tumors Requires the Estrogen Receptor and Interaction with the Extracellular Matrix Mol. Cancer Res., April 1, 2009; 7(4): 498 - 510. [Abstract] [Full Text] [PDF]

				C. E. Ford, E. J. Ekstrom, and T. Andersson From the Cover: Wnt-5a signaling restores tamoxifen sensitivity in estrogen receptor-negative breast cancer cells PNAS, March 10, 2009; 106(10): 3919 - 3924. [Abstract] [Full Text] [PDF]

				S. M. Fernandez, M. C. Lewis, A. S. Pechenino, L. L. Harburger, P. T. Orr, J. E. Gresack, G. E. Schafe, and K. M. Frick Estradiol-Induced Enhancement of Object Memory Consolidation Involves Hippocampal Extracellular Signal-Regulated Kinase Activation and Membrane-Bound Estrogen Receptors J. Neurosci., August 27, 2008; 28(35): 8660 - 8667. [Abstract] [Full Text] [PDF]

				M. Lombardi, G. Castoria, A. Migliaccio, M. V. Barone, R. Di Stasio, A. Ciociola, D. Bottero, H. Yamaguchi, E. Appella, and F. Auricchio Hormone-dependent nuclear export of estradiol receptor and DNA synthesis in breast cancer cells J. Cell Biol., July 28, 2008; 182(2): 327 - 340. [Abstract] [Full Text] [PDF]

				J. A. Greenberg, S. Somme, H. E. Russnes, A. D. Durbin, and D. Malkin The Estrogen Receptor Pathway in Rhabdomyosarcoma: A Role for Estrogen Receptor-{beta} in Proliferation and Response to the Antiestrogen 4'OH-Tamoxifen Cancer Res., May 1, 2008; 68(9): 3476 - 3485. [Abstract] [Full Text] [PDF]

				S. Chia, W. Gradishar, L. Mauriac, J. Bines, F. Amant, M. Federico, L. Fein, G. Romieu, A. Buzdar, J. F.R. Robertson, et al. Double-Blind, Randomized Placebo Controlled Trial of Fulvestrant Compared With Exemestane After Prior Nonsteroidal Aromatase Inhibitor Therapy in Postmenopausal Women With Hormone Receptor-Positive, Advanced Breast Cancer: Results From EFECT J. Clin. Oncol., April 1, 2008; 26(10): 1664 - 1670. [Abstract] [Full Text] [PDF]

				P. A. Pioli, A. L. Jensen, L. K. Weaver, E. Amiel, Z. Shen, L. Shen, C. R. Wira, and P. M. Guyre Estradiol Attenuates Lipopolysaccharide-Induced CXC Chemokine Ligand 8 Production by Human Peripheral Blood Monocytes J. Immunol., November 1, 2007; 179(9): 6284 - 6290. [Abstract] [Full Text] [PDF]

				C. T. Kesler, D. Gioeli, M. R. Conaway, M. J. Weber, and B. M. Paschal Subcellular Localization Modulates Activation Function 1 Domain Phosphorylation in the Androgen Receptor Mol. Endocrinol., September 1, 2007; 21(9): 2071 - 2084. [Abstract] [Full Text] [PDF]

				D. Nonclercq, F. Journe, I. Laios, C. Chaboteaux, R.-A. Toillon, G. Leclercq, and G. Laurent Effect of nuclear export inhibition on estrogen receptor regulation in breast cancer cells J. Mol. Endocrinol., August 1, 2007; 39(2): 105 - 118. [Abstract] [Full Text] [PDF]

				J. D. Wren, Y. Wu, and S.-W. Guo A system-wide analysis of differentially expressed genes in ectopic and eutopic endometrium Hum. Reprod., August 1, 2007; 22(8): 2093 - 2102. [Abstract] [Full Text] [PDF]

				D. Gallo, E. Mantuano, M. Fabrizi, C. Ferlini, S. Mozzetti, I. De Stefano, and G. Scambia Effects of a phytoestrogen-containing soy extract on the growth-inhibitory activity of ICI 182 780 in an experimental model of estrogen-dependent breast cancer Endocr. Relat. Cancer, June 1, 2007; 14(2): 317 - 324. [Abstract] [Full Text] [PDF]

				M. Lupien, M. Jeyakumar, E. Hebert, K. Hilmi, D. Cotnoir-White, C. Loch, A. Auger, G. Dayan, G.-A. Pinard, J.-M. Wurtz, et al. Raloxifene and ICI182,780 Increase Estrogen Receptor-{alpha} Association with a Nuclear Compartment via Overlapping Sets of Hydrophobic Amino Acids in Activation Function 2 Helix 12 Mol. Endocrinol., April 1, 2007; 21(4): 797 - 816. [Abstract] [Full Text] [PDF]

				M. Nichols The Fight Against Tamoxifen Resistance in Breast Cancer Therapy: A New Target in the Battle? Mol. Interv., February 1, 2007; 7(1): 13 - 16. [Abstract] [Full Text] [PDF]

				P. Fan, J. Wang, R. J. Santen, and W. Yue Long-term Treatment with Tamoxifen Facilitates Translocation of Estrogen Receptor {alpha} out of the Nucleus and Enhances its Interaction with EGFR in MCF-7 Breast Cancer Cells Cancer Res., February 1, 2007; 67(3): 1352 - 1360. [Abstract] [Full Text] [PDF]

				L. Zhao, K. O'Neill, and R. D. Brinton Estrogenic Agonist Activity of ICI 182,780 (Faslodex) in Hippocampal Neurons: Implications for Basic Science Understanding of Estrogen Signaling and Development of Estrogen Modulators with a Dual Therapeutic Profile J. Pharmacol. Exp. Ther., December 1, 2006; 319(3): 1124 - 1132. [Abstract] [Full Text] [PDF]

				B. M. Jaber, T. Gao, L. Huang, S. Karmakar, and C. L. Smith The Pure Estrogen Receptor Antagonist ICI 182,780 Promotes a Novel Interaction of Estrogen Receptor-{alpha} with the 3',5'-Cyclic Adenosine Monophosphate Response Element-Binding Protein-Binding Protein/p300 Coactivators Mol. Endocrinol., November 1, 2006; 20(11): 2695 - 2710. [Abstract] [Full Text] [PDF]

				A. Howell Pure oestrogen antagonists for the treatment of advanced breast cancer. Endocr. Relat. Cancer, September 1, 2006; 13(3): 689 - 706. [Abstract] [Full Text] [PDF]

				J. M. Garcia-Pedrero, E. Kiskinis, M. G. Parker, and B. Belandia The SWI/SNF Chromatin Remodeling Subunit BAF57 Is a Critical Regulator of Estrogen Receptor Function in Breast Cancer Cells J. Biol. Chem., August 11, 2006; 281(32): 22656 - 22664. [Abstract] [Full Text] [PDF]

				R. S. Bhattacharyya, A. V. Krishnan, S. Swami, and D. Feldman Fulvestrant (ICI 182,780) down-regulates androgen receptor expression and diminishes androgenic responses in LNCaP human prostate cancer cells. Mol. Cancer Ther., June 1, 2006; 5(6): 1539 - 1549. [Abstract] [Full Text] [PDF]

				X. Long and K. P. Nephew Fulvestrant (ICI 182,780)-dependent Interacting Proteins Mediate Immobilization and Degradation of Estrogen Receptor-{alpha} J. Biol. Chem., April 7, 2006; 281(14): 9607 - 9615. [Abstract] [Full Text] [PDF]

				L. Lipfert, J. E. Fisher, N. Wei, A. Scafonas, Q. Su, J. Yudkovitz, F. Chen, S. Warrier, E. T. Birzin, S. Kim, et al. Antagonist-Induced, Activation Function-2-Independent Estrogen Receptor {alpha} Phosphorylation Mol. Endocrinol., March 1, 2006; 20(3): 516 - 533. [Abstract] [Full Text] [PDF]

				H.-P. Yu, M. A. Choudhry, T. Shimizu, Y.-C. Hsieh, M. G. Schwacha, S. Yang, and I. H. Chaudry Mechanism of the salutary effects of flutamide on intestinal myeloperoxidase activity following trauma-hemorrhage: up-regulation of estrogen receptor-{beta}-dependent HO-1 J. Leukoc. Biol., February 1, 2006; 79(2): 277 - 284. [Abstract] [Full Text] [PDF]

				M. Fan, A. Park, and K. P. Nephew CHIP (Carboxyl Terminus of Hsc70-Interacting Protein) Promotes Basal and Geldanamycin-Induced Degradation of Estrogen Receptor-{alpha} Mol. Endocrinol., December 1, 2005; 19(12): 2901 - 2914. [Abstract] [Full Text] [PDF]

				H.-J. Kim, Y. I. Park, and M.-S. Dong Effects of 2,4-D and DCP on the DHT-Induced Androgenic Action in Human Prostate Cancer Cells Toxicol. Sci., November 1, 2005; 88(1): 52 - 59. [Abstract] [Full Text] [PDF]

				F. F. Zheng, R.-C. Wu, C. L. Smith, and B. W. O'Malley Rapid Estrogen-Induced Phosphorylation of the SRC-3 Coactivator Occurs in an Extranuclear Complex Containing Estrogen Receptor Mol. Cell. Biol., September 15, 2005; 25(18): 8273 - 8284. [Abstract] [Full Text] [PDF]

				K-M Rau, H-Y Kang, T-L Cha, S A Miller, and M-C Hung The mechanisms and managements of hormone-therapy resistance in breast and prostate cancers Endocr. Relat. Cancer, September 1, 2005; 12(3): 511 - 532. [Abstract] [Full Text] [PDF]

				R. F. Walther, E. Atlas, A. Carrigan, Y. Rouleau, A. Edgecombe, L. Visentin, C. Lamprecht, G. C. Addicks, R. J. G. Hache, and Y. A. Lefebvre A Serine/Threonine-rich Motif Is One of Three Nuclear Localization Signals That Determine Unidirectional Transport of the Mineralocorticoid Receptor to the Nucleus J. Biol. Chem., April 29, 2005; 280(17): 17549 - 17561. [Abstract] [Full Text] [PDF]